On Monday, the Federal Circuit found invalid Novozymes A/S’s patent covering an enzyme used to make ethanol. The ruling in favor of DuPont’s Danisco A/S affirms a lower court determination, which also found U.S. Patent Number 7,713,723 invalid “because its written description did not meet the requirement set out under U.S. law.” Finnegan represented DuPont in this matter.
Commentary
May 20, 2026
Award/Ranking
Finnegan Partner Antje Brambrink Shortlisted for Women in Business Law EMEA Award
May 13, 2026
Press Release
Finnegan Secures Decisive ITC Victory for Innoscience in Final Determination
May 11, 2026
Award/Ranking
Associates Rank Finnegan “Best of the Best” in BTI Associate Satisfaction Survey
May 7, 2026
Announcement
Finnegan Partner Ningling Wang Becomes President of Licensing Executives Society International
May 4, 2026
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.